Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Research has demonstrated that simultaneous GIP and GLP-1 receptor stimulation creates a synergistic insulin response and glucagonostatic effect significantly greater than what separate administration of each hormone produces
The dual GIP/GLP-1 mechanism of tirzepatide appears to provide a meaningful advantage over GLP-1-only stimulation from semaglutide
doi:10.2337/db14-1577 61
Benefits of Tirzepatide for Weight Loss Based on clinical trials, patients using Tirzepatide may experience: Substantial A1C reductions Increased weight loss Improvements in cardiometabolic measures Improved triglycerides levels Reduced appetite Decreased blood pressure Improved insulin sensitivity Conclusion Tirzepatide had an overall safety and tolerability profile, similar to other therapies approved for the treatment of obesity
US$ 28.28
US$ 21.51
US$ 28.41
US$ 26.11
